Skip to main content

Acorda Therapeutics, Inc.

ACORDelisted Apr 25, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001008848

Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in Acorda Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
35
+2 vs. Q1 2022
Shares held
6.65M
+3.30M (+98.6%) vs. Q1 2022
Total value
$3.08M
−$2.30M (−42.7%) vs. Q1 2022
New holders
9
11 more added
Sold out
7
6 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 35 institutions
Q1 2021: 37 institutionsQ2 2021: 37 institutionsQ3 2021: 36 institutionsQ4 2021: 34 institutionsQ1 2022: 34 institutionsQ2 2022: 35 institutionsQ3 2022: 36 institutionsQ4 2022: 36 institutionsQ1 2023: 30 institutionsQ2 2023: 15 institutionsQ3 2023: 16 institutionsQ4 2023: 15 institutionsQ1 2024: 17 institutionsQ2 2024: 2 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $3.08M
Q1 2021: $18.0MQ2 2021: $18.1MQ3 2021: $14.7MQ4 2021: $9.48MQ1 2022: $5.42MQ2 2022: $3.08MQ3 2022: $1.91MQ4 2022: $4.09MQ1 2023: $3.71MQ2 2023: $1.94MQ3 2023: $2.30MQ4 2023: $2.33MQ1 2024: $2.13MQ2 2024: $8.00KQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ACOR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20242$8.00K
Q1 202417$2.13M
Q4 202315$2.33M
Q3 202316$2.30M
Q2 202315$1.94M
Q1 202330$3.71M
Q4 202236$4.09M
Q3 202236$1.91M
Q2 202235$3.08M
Q1 202234$5.42M
Q4 202134$9.48M
Q3 202136$14.7M
Q2 202137$18.1M
Q1 202137$18.0M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Acorda Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding ACOR in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Davidson Kempner Capital Management LP2,395,668$1.11M0.02%+2,395,668New
Canyon Capital Advisors LLC1,193,988$556.0K0.04%+544,957+84.0%Added
Renaissance Technologies LLC901,318$420.0K0.00%+194,100+27.4%Added
Acadian Asset Management LLC682,670$318.0K0.00%+214,931+46.0%Added
Millennium Management LLC311,509$145.0K0.00%+270,588+661.2%Added
Vanguard Group Inc158,061$73.0K0.00%−183,484−53.7%Reduced
Virtu Financial LLC145,318$68.0K0.01%+145,318New
BlackRock Inc.139,522$66.0K0.00%−25,952−15.7%Reduced
HN Saltoro Capital, LP108,827$51.0K0.08%+93,979+632.9%Added
Bridgeway Capital Management, LLC101,706$47.0K0.00%−142,384−58.3%Reduced
Wells Fargo & Company74,671$35.0K0.00%+24,796+49.7%Added
Prudential Financial Inc60,200$28.0K0.00%+60,200New
Geode Capital Management, LLC46,721$21.0K0.00%00.0%Unchanged
Susquehanna International Group, LLP45,880$21.0K0.00%+45,880New
HRT Financial LP39,319$18.0K0.00%+39,319New
State Street Corp31,648$15.0K0.00%00.0%Unchanged
United Asset Strategies, Inc.27,100$13.0K0.00%00.0%Unchanged
UBS Group AG28,698$13.0K0.00%+25,883+919.5%Added
Tower Research Capital LLC (TRC)27,234$13.0K0.00%+26,655+4,603.6%Added
Two Sigma Securities, LLC27,692$13.0K0.00%+27,692New
Northern Trust Corp26,118$12.0K0.00%−510−1.9%Reduced
Two Sigma Advisers, LP14,400$7.00K0.00%00.0%Unchanged
Verition Fund Management LLC13,641$6.00K0.00%+13,641New
Ergoteles LLC13,300$6.00K0.00%+13,300New
Simon Quick Advisors, LLC14,211$6.00K0.00%+14,211New
Simplex Trading, LLC7,870$3.00K0.00%+2,178+38.3%Added
Russell Investments Group, Ltd.6,000$2.00K0.00%00.0%Unchanged
Morgan Stanley5,351$2.00K0.00%+552+11.5%Added
JPMorgan Chase & Co11$00.00%+3+37.5%Added
Bank of America Corp1$00.00%00.0%Unchanged
First Manhattan Co50$00.00%00.0%Unchanged
Royal Bank of Canada293$00.00%−43−12.8%Reduced
IMA Wealth, Inc.17$00.00%00.0%Unchanged
JNBA Financial Advisors1$00.00%00.0%Unchanged
Advisor Group Holdings, Inc.1$00.00%−84−98.8%Reduced
Point72 Asset Management, L.P.0$00.00%−464,276−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−19,752−100.0%Sold out
Jane Street Group, LLC0$00.00%−13,505−100.0%Sold out
Citigroup Inc0$00.00%−1,658−100.0%Sold out
Federated Hermes, Inc.0$00.00%−755−100.0%Sold out
Capital Advisors, Ltd. LLC0$00.00%−37−100.0%Sold out
Private Capital Group, LLC0$00.00%−10−100.0%Sold out
Susquehanna Fundamental Investments, LLC––––Not filed